Home Health NAFDAC raises concerns over fake COVID-19 AstraZeneca vaccine
HealthNews

NAFDAC raises concerns over fake COVID-19 AstraZeneca vaccine

Share
Share

The National Agency for Food and Drug Administration and Control (NAFDAC) has urged Nigerians to check for the original label on the Astrazeneca vaccine being administered on them.

In a statement issued yesterday, the agency said the warning was imperative to ensure people did not risk being vaccinated with the fake Astrazeneca vaccine.

NAFDAC’s Director-General, Prof. Mojisola Adeyeye, who signed the statement explained that the original Oxford Astrazeneca University (AZOU) vaccine, had been contracted to India’s world largest vaccine manufacturer, Serum Institute of India (SIIPL), to produce in large quantity.

AZOU gave the license of its vaccine to Serum Institute of India PVT Ltd, (SIIPL), to manufacture this vaccine at a commercial scale. SIIPL is the largest vaccine manufacturer in the world and the company got the license by signing the manufacturing agreement.

“SIIPL gave the vaccine the trade name COVISHIELD, it is the result of a cooperation and a technology transfer from AstraZeneca – University of Oxford to SIIPL.

“SIIPL is now the world’s largest vaccine manufacturer by number of doses produced and sold globally.

“More than 1.5 billion doses, which include Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella,” she said.

Adeyeye added that the vaccines manufactured by SIIPL were accredited by the World Health Organisation (WHO), and were being used in about 170 countries across the globe in their national immunisation programme.

She added that both COVISHIELD manufactured by SIIPL and COVID-19 vaccine Astrazeneca, manufactured by Astrazeneca/Oxford University vaccine are the same vaccine.

According to Adeyeye, ChAdOx1 nCoV- 19 coronavirus vaccines (Recombinant), COVISHIELD, was granted Emergency Use Listing (EUL) by the World Health Organisation on Feb.15, and that it was one of the listed vaccines under the COVAX Facility.

(Thisday)

Please follow and like us:
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Member

Don't Miss

Moniepoint hits ₦1trn milestone in SME Loans, marks 10 years of empowering small businesses‎‎

By Chioma Obinagwam Moniepoint Inc., Nigeria’s definitive platform for small businesses and Africa’s all-in-one financial ecosystem, today released its 2025 Year in Review,...

‎Why Nigeria’s Banks Still on Shaky Ground with Big Profits, Weak Capital

By Blaise Udunze‎‎Despite the fragile 2024 economy grappling with inflation, currency volatility, and weak growth, Nigeria’s banking industry was widely portrayed as successful...

Related Articles

Moniepoint hits ₦1trn milestone in SME Loans, marks 10 years of empowering small businesses‎‎

By Chioma Obinagwam Moniepoint Inc., Nigeria’s definitive platform for small businesses and...

Why 2026 could be your year of extraordinary breakthroughs‎

By Chioma Obinagwam‎‎Year 2026 will mark the end of ordinary living for...

‎Seplat Energy ends routine gas flaring, leads Nigeria’s net-zero drive‎

By Chioma Obinagwam‎‎ Seplat Energy Plc is reinforcing its commitment to responsible,...

‎What Ghana’s Crypto Regulation Actually Means for Businesses‎

By Gillian Darko, Vice President of Strategy, Yellow Card‎‎Across Africa, 2025 marked...